The Synergo® system has been successfully used in leading medical centers in the
European Community and Israel. Thousand of patients have been treated during
the years and were carefully monitored for any side effects and complications.
Most side effects and complications witnessed are well known and have been
reported with intravesical chemotherapy instillations (without hyperthermia).
Side effects that were observed were transient events that normally had no
lasting effect on bladder function, superficial, resolved with minimal medical
intervention and without significant residual effects during the course of the treatment.
The complications observed were successfully treated with standard procedures.
Similar side effects were witnessed during Adjuvant (Prophylactic) and Neo-Adjuvant
(Ablative) Synergo® treatments.
Medical Enterprises Europe B.V. 147A Amsterdamseweg, 1182GT Amstelveen , The Netherlands Tel: 31(0)20 6423719 Fax: 31(0)20 6421161
R&D Center: MEL Medical Enterprises Ltd. 6 Odem St.Petah-Tikva, 49170, ISRAEL
Tel: 972(0)3 9244830 Fax: 972(0)3 9245340
